search icon

    Market Snapshot

    • S&P Futures

      3,814.5

    • Dow Futures

      30,961

    • Nasdaq Futures

      11,557.75

    blog search icon

    Aquestive Therapeutics, Inc.

    (NASDAQ:AQST)

    $0.63

    $-0.01

    -1.53%

    Aquestive Therapeutics, Inc. Chart

    AQST Stock Price Today

    Aquestive Therapeutics, Inc. (AQST) stock declined over -1.53% intraday to trade at $0.63 a share on NASDAQ. The stock opened with a loss of -7.35% at $0.64 and touched an intraday high of $0.654, falling -1.56% against the last close of $0.64. The stock went to a low of $0.618 during the session.

    Stock Snapshot

    $0.64

    Prev. Close

    31.4 Million

    Market Cap

    $0.618

    Day Low

    $0.64

    Open

    41.47 Million

    Number of Shares

    $0.654

    Day High

    -

    P/E ratio

    -1.74

    EPS (TTM)

    0.68

    Cash Flow per Share

    3.47

    Free Float in %

    -1.50

    Book Value

    438,641

    Volume

    Aquestive Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$0.64$0.654$0.618$0.63439,500
    2022-06-30$0.68$0.68$0.626$0.64891,700
    2022-06-29$0.73$0.73$0.67$0.688756,300
    2022-06-28$0.755$0.76$0.72$0.732408,900
    2022-06-27$0.785$0.79$0.722$0.749548,800
    2022-06-24$0.774$0.79$0.7$0.742,408,300
    2022-06-23$0.703$0.773$0.7$0.76893,500
    2022-06-22$0.68$0.741$0.68$0.713921,800
    2022-06-21$0.71$0.757$0.65$0.7161,320,000
    2022-06-17$0.75$0.76$0.7$0.7062,409,000

    Contact Details

    30 Technology Drive
    Warren, NJ 07059
    United States

    Webiste:AQST

    908 941 1900

    Company Information

    Employees-

    Beta3.43

    Sales or Revenue50.83 Million

    5Y Sales Change-0.40%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

    Frequently Asked Questions

    icon

    What is the current Aquestive Therapeutics, Inc. (AQST) stock price?

    Aquestive Therapeutics, Inc. (NASDAQ: AQST) stock price is $0.63 as of the last check on Friday, July 1. During the trading session, AQST stock reached the peak price of $0.654 while $0.618 was the lowest point it dropped to.

    icon

    AQST's industry and sector of operation?

    The NASDAQ listed AQST is part of Pharmaceuticals industry that operates in the broader Health Care sector. Aquestive Therapeutics, Inc. , a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally.

    icon

    Who are the executives of AQST?

    Mr. Keith J. Kendall
    CEO, Pres & Director
    Mr. Daniel Barber
    Sr. VP & COO
    Mr. A. Ernest Toth Jr.
    Sr. VP & CFO
    Mr. Alexander Mark Schobel
    Chief Innovation & Technology Officer

    icon

    What is the AQST stock price today?

    AQST stock traded closed the last session at $0.63, which is $-0.01 or -1.53% lower than its previous close of $0.64. AQST's current trading price is 0.64% lower than its 52-week high of $6.40 where as its distance from 52-week low of 0.63% is -90.16%.

    icon

    How many employees does AQST have?

    Number of AQST employees currently stands at -. AQST operates from 30 Technology Drive, Warren, NJ 07059, United States.

    icon

    Link for AQST official website?

    Official Webiste of $AQST is: https://www.aquestive.com

    icon

    How do I contact AQST?

    AQST could be contacted at AQST operates from 30 Technology Drive, Warren, NJ 07059, United States, or at phone #908 941 1900 and can also be accessed through its website.

    icon

    How many shares of AQST are traded daily?

    AQST stock volume for the day was 438,641 shares while in the previous session number of AQST shares traded was 439,500 . The average number of AQST shares traded daily for last 3 months was 717.15 Thousands.

    icon

    How much did AQST change today?

    The percentage change in AQST stock occurred in the recent session was -1.53% while the dollar amount for the price change in AQST stock was $-0.01.

    icon

    What price range AQST stock been trading in?

    In the recent session, the day high for AQST stock was $0.654 while the low for AQST stock touched on the day was $0.618.

    icon

    What is the market cap of AQST currently?

    The market value of AQST currently stands at 31.4 Million with its latest stock price at $0.63 and 41.47 Million of its shares outstanding.